Here are five observations:
1. Europe and Israel CE-marked the NUsurface Meniscus Implant in 2008 and 2011, respectively.
2. A clinical trial examining NUsurface Meniscus Implant’s safety is currently underway.
3. Dr. Bankston earned his medical degree from the Louisiana State University School of Medicine in New Orleans and completed his residency at the University of Alabama School of Medicine in Birmingham. He underwent his shoulder and elbow fellowship at OrthoCarolina Sports Medicine in Charlotte, N.C.
4. Dr. Easton earned his medical degree from the Louisiana State University School of Medicine and completed his residency at the Louisiana State University Health Sciences Center in New Orleans. He underwent his adult reconstruction surgery fellowship at the Cleveland Clinic.
5. Active Implants is a medical device company developing orthopedic implant solutions.
More articles on devices and implants:
Global spine surgery robots market to hit $2.77B by 2022 — 4 points
NuVasive stock reaches new 52-week high: 3 points
Asia Pacific spine surgery devices market to reach $2.2B by 2019 — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
